Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial.
Manuela VayMarleen Julia MeyerAntje BlankGisela SkoppPeter RoseMladen Vassilev TzvetkovGerd MikusPublished in: Clinical pharmacokinetics (2021)
EudraCT2017-001801-34.